Literature DB >> 1033766

Inhibition of purine nucleotide biosynthesis by 3-deazaguanine, its nucleoside and 5'-nucleotide.

D G Streeter, H H Koyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1033766     DOI： 10.1016/0006-2952(76)90041-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  12 in total

Review 1.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

2.  Studies on the mechanism of 3-deazaguanine cytotoxicity in L1210-sensitive and -resistant cell lines.

Authors:  G Singh; M K Luna; B Ardalan
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Dezaguanine mesylate: a new antipurine antimetabolite.

Authors:  W R Leopold; D W Fry; T J Boritzki; J A Besserer; I C Pattison; R C Jackson
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

4.  Antiviral activity of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid.

Authors:  L B Allen; J H Huffman; P Dan Cook; R B Meyer; R K Robins; R W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

5.  Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro.

Authors:  F Kawana; S Shigeta; M Hosoya; H Suzuki; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

6.  Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity.

Authors:  D F Smee; R W Sidwell; S M Clark; B B Barnett; R S Spendlove
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

7.  Studies on the mechanism of cytotoxicity of 3-deazaguanosine in human cancer cells.

Authors:  T Page; S J Jacobsen; R M Smejkal; J Scheele; W L Nyhan; J H Mangum; R K Robins
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  Comparative activities of several nucleoside analogs against influenza A, B, and C viruses in vitro.

Authors:  S Shigeta; K Konno; T Yokota; K Nakamura; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

9.  Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin.

Authors:  J J Kirsi; P A McKernan; N J Burns; J A North; B K Murray; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

10.  Clinical pharmacokinetics of 3-deazaguanine.

Authors:  L Pendyala; P J Creaven; L R Whitfield
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.